<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The criteria for determining response to therapy and establishing <z:mp ids='MP_0009277'>brain tumor</z:mp> recurrence are presented </plain></SENT>
<SENT sid="1" pm="."><plain>Basing their conclusions on a series of more than 500 patients, the authors contend that serial scintiscans and computerized axial tomograms can be used to determine accurately the response to therapy and recurrence or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> regrowth </plain></SENT>
<SENT sid="2" pm="."><plain>The problems in evaluating response and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence are discussed, with emphasis on those relating to concurrent <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> therapy and medical conditions such as <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:mp ids='MP_0008817'>hematomas</z:mp>, and drug side-effects </plain></SENT>
</text></document>